INS and cancer: Also, the signaling pathways contributing to deterioration of immune tissues, such as insulin signaling, play a critical role in metabolic dysfunctions and tumorigenesis, making them valuable targets for therapeutic intervention in diseases such as diabetes and cancer (Saltiel and Kahn, 2001).